UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORGN
2401
DELISTED
Origin Materials
ORGN
| $313K | ﹤0.01% |
2,440
-63
| -3% | -$9.3K |
|
2402
RCI Hospitality Holdings
RICK
$215M
| $312K | ﹤0.01% |
3,994
| – | – |
|
2403
AvePoint
AVPT
$2.71B
| $311K | ﹤0.01% |
+75,464
| New | +$341K |
|
2404
First Community Bankshares
FCBC
$911M
| $309K | ﹤0.01% |
12,341
-5,001
| -29% | -$154K |
|
2405
RLX Technology
RLX
$2.46B
| $308K | ﹤0.01% |
106,300
| – | – |
|
2406
BlueLinx
BXC
$706M
| $308K | ﹤0.01% |
4,536
-3,383
| -43% | -$274K |
|
2407
MaxCyte
MXCT
$126M
| $308K | ﹤0.01% |
62,213
-687
| -1% | -$3.38K |
|
2408
Unisys
UIS
$217M
| $308K | ﹤0.01% |
79,261
+26,394
| +50% | +$128K |
|
2409
Xponential Fitness
XPOF
$211M
| $304K | ﹤0.01% |
+10,000
| New | +$265K |
|
2410
Atea Pharmaceuticals
AVIR
$420M
| $302K | ﹤0.01% |
90,068
| – | – |
|
|
CMBT
2411
CMB.TECH NV
CMBT
$4.73B
| $301K | ﹤0.01% |
17,898
| – | – |
|
2412
Vertex
VERX
$1.94B
| $299K | ﹤0.01% |
+14,473
| New | +$223K |
|
2413
World Acceptance Corp
WRLD
$873M
| $298K | ﹤0.01% |
3,580
| – | – |
|
2414
Arlo Technologies
ARLO
$1.65B
| $298K | ﹤0.01% |
49,116
-10,992
| -18% | -$48.7K |
|
2415
PMV Pharmaceuticals
PMVP
$63.5M
| $297K | ﹤0.01% |
62,355
-127,830
| -67% | -$900K |
|
2416
Nuvation Bio
NUVB
$2.32B
| $297K | ﹤0.01% |
178,816
+32,226
| +22% | +$65.3K |
|
2417
Quanterix
QTRX
$190M
| $294K | ﹤0.01% |
26,090
-8,100
| -24% | -$103K |
|
|
GOEV
2418
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $290K | ﹤0.01% |
966
+376
| +64% | +$159K |
|
2419
Butterfly Network
BFLY
$2.35B
| $290K | ﹤0.01% |
154,216
| – | – |
|
|
NGMS
2420
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $289K | ﹤0.01% |
19,000
| – | – |
|
2421
NETGEAR
NTGR
$635M
| $289K | ﹤0.01% |
15,589
-17,034
| -52% | -$320K |
|
|
SPNS
2422
DELISTED
Sapiens International
SPNS
| $287K | ﹤0.01% |
13,207
| – | – |
|
2423
Peapack-Gladstone Financial
PGC
$812M
| $286K | ﹤0.01% |
9,662
+1,998
| +26% | +$70.8K |
|
2424
Nuveen ESG Large-Cap Value ETF
NULV
$2.27B
| $286K | ﹤0.01% |
+8,394
| New | +$289K |
|
|
WE
2425
DELISTED
WeWork Inc.
WE
| $282K | ﹤0.01% |
9,060
| – | – |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.